Related Experiment Videos
Consequences of nonadaptive alterations in cancer
1Deltagen Proteomics, Inc., Salt Lake City, Utah 84108, USA. akamb@deltagenpro.com
Molecular Biology of the Cell
|June 17, 2003
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Multi-targeted, NOT gated CAR-T cells as a strategy to protect normal lineages for blood cancer therapy.
Frontiers in immunology·2025
Geometric parameters that affect the behavior of logic-gated CAR T cells.
Frontiers in immunology·2024
Chimeric Antigen Receptors Directed at Mutant KRAS Exhibit an Inverse Relationship Between Functional Potency and Neoantigen Selectivity.
Cancer research communications·2023
HLA-A∗02-gated safety switch for cancer therapy has exquisite specificity for its allelic target antigen.
Molecular therapy oncolytics·2022
In vivo clustering of oskar mRNA is driven by RNA concentration, RNA binding proteins, and an RNA palindrome.
Molecular biology of the cell·2026
Cdk1 and PP2A constitute a molecular switch controlling orderly degradation of atypical E2Fs.
Molecular biology of the cell·2026
Unlocking the bacterial condensome: from 'dark matter' to design.
Molecular biology of the cell·2026
The identification of drp1 patient mutations that limit interactions with mff.
Molecular biology of the cell·2026
PES-8, a ZP-like protein, is required for Cytoskeletal Organization and Contractility in the C. elegans Spermatheca.
Molecular biology of the cell·2026
Vimentin bridges scales to convert polarized cell locomotion into coordinated collective migration.
Molecular biology of the cell·2026
Exosome therapy for knee osteoarthritis: a network meta-analysis based on rat models.
Stem cells translational medicine·2026
Tobacco and Marijuana Induce Adverse Effects on Cardiac Function and Platelet Activity and Reduce Tissue Preservation Following Myocardial Infarction.
American journal of physiology. Heart and circulatory physiology·2026
Danburstotug, an anti-PD-L1 antibody, in relapsed/refractory extra-nodal natural killer/T-cell lymphoma: The phase 2 DISTINKT study.
British journal of haematology·2026